Agile Therapeutics reported $14.55M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Adma Biologics ADMA:US $ 17.67M 1.88M
Agile Therapeutics AGRX:US $ 14.55M 1.94M
Bayer BAYN:GR 3.94B 346M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
JAZZ PHA JAZZ:US 308.81M 53.95M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Merk MRK:US $ 2.3B 518M
Pacira Pharmaceuticals PCRX:US $ 64.26M 13.06M
Pain Therapeutics PTIE:US $ 2.92M 1.19M
Teva Pharmaceutical Industries TEVA:US 819M 39M
Therapeuticsmd TXMD:US 39.3M 8.61M